Bioiberica, a global Life Science company committed to improving the health and well-being of people, animals and plants, announced a new strategic agreement with Mill Tech Co., Inc. for the exclusive distribution of its hydrolysed protein range for animal nutrition, Palbio™, in South Korea. The agreement comes after the successful fulfilment of rigorous export requirements to the country, enabled by Bioiberica’s robust production process, which ensures the biosecurity of its entire animal nutrition portfolio. This move marks a milestone in the companies’ long-standing strategic partnership, solidifying their collective offering in South Korea. The companies have been working together for several years to distribute Bioiberica’s Nucleoforce™ range, used to support the immunological and intestinal health of farm animals and aquaculture species.

Palbio™ 50 RD is now authorised for distribution in more than 40 countries, including the recent addition of South Korea. It is a safe source of high-quality hydrolysed proteins in the form of L-α-amino acids and bioactive peptides. Palbio™ 50 RD have been shown to positively affect the intestinal health of young animals, improving digestion and feed intake to ensure productive improvements in pig, poultry, and fish.